VIB Vermögen Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for VIB Vermögen.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Real Estate earnings growth | 89.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
When Should You Buy VIB Vermögen AG (ETR:VIH1)?
Dec 20Is VIB Vermögen (ETR:VIH1) Using Too Much Debt?
Jun 21Is Now The Time To Look At Buying VIB Vermögen AG (ETR:VIH1)?
May 30VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate
Mar 29VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 18Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?
Feb 11Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?
Sep 06Is VIB Vermögen (ETR:VIH1) A Risky Investment?
Oct 15VIB Vermögen (ETR:VIH1) Has Compensated Shareholders With A Respectable 100% Return On Their Investment
Mar 11A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE
Feb 18You Have To Love VIB Vermögen AG's (ETR:VIH1) Dividend
Jan 19Here's What VIB Vermögen AG's (ETR:VIH1) Shareholder Ownership Structure Looks Like
Dec 25Shareholders Of VIB Vermögen (ETR:VIH1) Must Be Happy With Their 94% Return
Dec 06A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE
Nov 18In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as VIB Vermögen has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2023 | 108 | 84 | 71 | 71 | N/A |
3/31/2023 | 128 | 76 | N/A | N/A | N/A |
12/31/2022 | 128 | 54 | 68 | 68 | N/A |
9/30/2022 | 137 | 41 | N/A | N/A | N/A |
6/30/2022 | 126 | 49 | 74 | 74 | N/A |
3/31/2022 | 106 | 143 | N/A | N/A | N/A |
12/31/2021 | 102 | 30 | 75 | 75 | N/A |
9/30/2021 | 101 | 54 | N/A | N/A | N/A |
6/30/2021 | 98 | 53 | 69 | 71 | N/A |
3/31/2021 | 96 | 71 | N/A | N/A | N/A |
12/31/2020 | 94 | 66 | 64 | 65 | N/A |
9/30/2020 | 94 | 71 | N/A | N/A | N/A |
6/30/2020 | 93 | 67 | 64 | 64 | N/A |
3/31/2020 | 92 | 64 | N/A | N/A | N/A |
12/31/2019 | 91 | 63 | 69 | 69 | N/A |
9/30/2019 | 90 | 58 | N/A | N/A | N/A |
6/30/2019 | 89 | 60 | 67 | 67 | N/A |
3/31/2019 | 88 | 59 | N/A | N/A | N/A |
12/31/2018 | 87 | 58 | 61 | 61 | N/A |
9/30/2018 | 86 | 58 | N/A | N/A | N/A |
6/30/2018 | 85 | 53 | 61 | 61 | N/A |
3/31/2018 | 85 | 51 | N/A | N/A | N/A |
12/31/2017 | 84 | 52 | 59 | 59 | N/A |
9/30/2017 | 83 | 49 | N/A | N/A | N/A |
6/30/2017 | 82 | 50 | 57 | 57 | N/A |
3/31/2017 | 81 | 50 | N/A | N/A | N/A |
12/31/2016 | 80 | 47 | N/A | 58 | N/A |
9/30/2016 | 79 | 43 | N/A | N/A | N/A |
6/30/2016 | 78 | 44 | N/A | 56 | N/A |
3/31/2016 | 77 | 40 | N/A | N/A | N/A |
12/31/2015 | 75 | 40 | N/A | 54 | N/A |
9/30/2015 | 73 | 37 | N/A | N/A | N/A |
6/30/2015 | 72 | 32 | N/A | N/A | N/A |
3/31/2015 | 71 | 32 | N/A | N/A | N/A |
12/31/2014 | 70 | 31 | N/A | 48 | N/A |
9/30/2014 | 69 | 29 | N/A | N/A | N/A |
6/30/2014 | 68 | 28 | N/A | N/A | N/A |
3/31/2014 | 66 | 27 | N/A | N/A | N/A |
12/31/2013 | 65 | 27 | N/A | 48 | N/A |
9/30/2013 | 64 | 25 | N/A | N/A | N/A |
6/30/2013 | 63 | 25 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if VIH1's forecast earnings growth is above the savings rate (0.6%).
Earnings vs Market: Insufficient data to determine if VIH1's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if VIH1's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if VIH1's revenue is forecast to grow faster than the German market.
High Growth Revenue: Insufficient data to determine if VIH1's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VIH1's Return on Equity is forecast to be high in 3 years time